Recent market projections have unveiled a promising trajectory for the MENA syringes and cannula market, signaling remarkable growth prospects. Valued at USD 1.3 billion in 2021, the market is poised to escalate at a robust Compound Annual Growth Rate (CAGR) of 6.4% over the forecast period, reaching an impressive USD 2.4 billion by 2031.
A key catalyst fueling this expansion is the overwhelming dominance of the disposable segment. In 2020, disposables held an authoritative 87.3% share of the total market, reflecting a steadfast preference for disposable syringes and cannulas within the MENA region. This trend is expected to persist and further fortify the market’s growth trajectory in the years ahead.
To Get the Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14736
The steady rise in demand for syringes and cannulas is attributed to several factors, including advancements in healthcare infrastructure and the increasing emphasis on healthcare safety protocols. These elements are driving the adoption of disposable medical devices, ensuring patient safety and minimizing the risks associated with cross-contamination.
The surge in market valuation is a testament to the region’s commitment to enhancing healthcare services. Governments and healthcare organizations in various MENA countries are aligning efforts to ensure the availability of quality medical devices and improved patient care.
The MENA syringes & cannula market is forecasted to maintain this upward trajectory, further bolstered by technological advancements and an increasing focus on patient-centric healthcare solutions. As the market continues to evolve, innovations in syringe and cannula technologies are expected to drive growth, enhancing patient comfort and safety.
According to an FMI analyst, “rising diabetes incidence and growing preference for cosmetic surgeries among individuals are expected to create opportunities for growth in the MENA syringers & cannula market.”
Key Takeaways:
- In 2020, the medical protective equipment segment accounted for 59.8% of the total market share.
- In 2020, the disposables segment accounted for 87.3% of the MENA syringes & cannula market.
- In terms of distribution channels, institutional sales are the dominant segment, accounting for approximately 63.8% of the total market share in 2020.
- Saudi Arabia held 16.2% of the total market share in 2020, a trend that is expected to continue throughout the forecast period.
Get Customization on This Report: https://www.futuremarketinsights.com/customization-available/rep-gb-14736
Competition Landscape:
- To gain a competitive advantage, key players in the MENA syringes & cannulas market are launching novel products. They are also expanding their footprint through mergers, acquisitions, and collaborations. As an example:
- In June 2021, Becton Dickinson and Company received an order for needles and syringes to participate in a vaccination drive in 40 countries, including Saudi Arabia, Germany, and South Africa.
- In August 2021, Hindustan Syringes and Medical Devices Ltd met a milestone target of producing 1 billion auto-disposable syringes for COVID 19 vaccinations. The company now has the capacity to produce 50 crore AD syringes per year.
Key Market Players:
- Ambu A/S
- Becton, Dickinson and Company
- Cardinal Health
- Braun Medical Inc.
- Medline Industries Inc.
- Nipro Corporation
- Terumo Corporation
- Hindustan Syringes & Medical Devices Ltd.
- Schott Kaisha Private Limited
- Edwards Lifesciences Corporation
Purchase Now to Access: https://www.futuremarketinsights.com/checkout/14736
Key Market Segments Covered in MENA Syringes & Cannula Industry Research:
By Product:
- Syringes
- Disposable Hypodermic Syringes
- Auto Disposable Syringes
- Safety Syringes
- Cannula
- Neonatal Cannulae
- Straight Cannulae
- Winged Cannulae
- Cannulae with Wings & Port
- Medical Protective Equipment
- Medical Masks
- Surgical Masks
- N95 Respirators
- Medical Gloves
- Vacutainers
- Blood Collection Needles
By Usage:
- Reusable
- Disposable
By Distribution Channel:
- Institutional Sales
- Hospitals
- Ambulatory Surgical Centres
- Office-based Clinics
- Skilled Nursing Facilities & Long Term Care Centres
- Retail Sales
- Retail Pharmacies
- Drug Stores
- Retail Stores (Hypermarket/Supermarket)
- Online Sales
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
